Aripiprazole once-monthly 400 mg for long-term maintenance treatment of schizophrenia: a 52-week open-label study

BACKGROUND: Long-term maintenance treatment with an antipsychotic is often required to prevent relapse and mitigate functional deterioration in patients with schizophrenia. AIMS: This study assessed the long-term safety, tolerability, and maintenance of the therapeutic effect of aripiprazole once-mo...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:NPJ Schizophr
Päätekijät: Peters-Strickland, Timothy, Baker, Ross A, McQuade, Robert D, Jin, Na, Eramo, Anna, Perry, Pamela, Johnson, Brian R, Duca, Anna, Sanchez, Raymond
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Nature Publishing Group 2015
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4849461/
https://ncbi.nlm.nih.gov/pubmed/27336044
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/npjschz.2015.39
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia